Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · IEX Real-Time Price · USD
+0.11 (1.93%)
At close: Feb 23, 2024, 4:00 PM
-0.08 (-1.38%)
After-hours: Feb 23, 2024, 7:48 PM EST

Company Description

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products.

The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders.

This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson's disease.

The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs.

This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers.

It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies.

The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018.

Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals logo
Country United States
Founded 2002
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 7,600
CEO Chirag K. Patel

Contact Details

400 Crossing Boulevard
Bridgewater, New Jersey 08807
United States
Phone 908 947 3120

Stock Details

Ticker Symbol AMRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001723128
CUSIP Number 03168L105
ISIN Number US03168L1052
SIC Code 2834

Key Executives

Name Position
Chirag K. Patel Co-Founder, Co-Chief Executive Officer, President and Director
Chintu Patel R.Ph. Co-Founder, Co-Chief Executive Officer and Director
Anastasios G. Konidaris Executive Vice President and Chief Financial Officer
Jason B. Daly Esq. Senior Vice President, Chief Legal Officer and Corporate Secretary
Nikita Shah Executive Vice President and Chief Human Resources Officer
Andrew S. Boyer Executive Vice President and Chief Commercial Officer of Generics
Anthony DiMeo Head of Investor Relations
Gregory Sgammato Senior Vice President of Corporate Development
Pranav Mehta Senior Vice President of Strategic Sourcing and Supply Management
Sanjay Kumar Jain Ph.D. President of India Operations

Latest SEC Filings

Date Type Title
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2024 8-K Current Report
Jan 5, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Jan 3, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Dec 27, 2023 CERT Certification by an exchange approving securities for listing
Dec 26, 2023 25 Filing
Dec 26, 2023 8-A12B Registration of securities
Dec 15, 2023 8-K Current Report
Dec 15, 2023 8-K/A [Amend] Current report
Dec 12, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals